EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Evaluating Tranexamic Acid Dosing Strategies for Postpartum Hemorrhage: A Population Pharmacokinetic Approach in Pregnant Individuals

Allison Dunn iD, Mina Felfeli, Sebastian M Seifert, Sixtine Gilliot, Anne-Sophie Ducloy-Bouthors, Haleem Shakur-Still, Amber Geer, Stanislas Grassin-Delyle, Naomi L Luban, Johannes N van den Anker, Jogarao V S Gobburu iD, Ian Roberts und 1 weitere

The Journal of Clinical Pharmacology · 2025

DOI: 10.1002/jcph.70031 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Pharmacology, 2025. Verfasst von Allison Dunn und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Antifibrinolytic Agents, Postpartum Hemorrhage, Tranexamic Acid. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tranexamic acid (TXA) is used for the treatment and occasionally prevention of postpartum hemorrhage (PPH); however, questions still remain regarding dosing regimen optimization. This study evaluated TXA pharmacokinetic (PK) data from four clinical trials (NCT: 04274335, 03287336, 00872469, and 02797119) conducted in pregnant participants receiving intravenous, intramuscular, or oral TXA to prevent or treat PPH. The goal of this analysis was to comprehensively characterize TXA PK in a large, heterogeneous population of pregnant individuals to (1) assess the need for weight‐based dosing and (2) compare exposure target attainment for alternative routes of administration. A population PK analysis was performed using nonlinear mixed‐effects modeling in Pumas, and a stepwise approach was implemented to select the structural model and identify significant covariates. A total of 211 pregnant participants who received between 0.35 and 4 g of TXA intravenously, orally, or intramuscularly offered 1303 TXA plasma concentrations for model development. A two‐compartment model with first‐order elimination and first‐order absorption for both intramuscular and oral administration best described the disposition of TXA. Actual body weight was the only statistically significant covariate identified, but inclusion into the model did not explain a substantial amount of the observed variability. Simulations of virtual pregnant individuals indicated minimal differences in TXA exposure between fixed and weight‐based dosing regimens, supporting the use of fixed dosing. Intramuscular TXA was additionally found to be a viable alternative to intravenous administration, achieving similar target exposure metrics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifibrinolytic AgentsPostpartum HemorrhageTranexamic AcidAdultFemaleHumansPregnancyYoung AdultAdministration, OralDose-Response Relationship, DrugInjections, IntramuscularModels, Biological

Stichwörter der Autor:innen

modelingpharmacokineticspostpartum hemorrhagesimulationtranexamic acid

Substanzen

Antifibrinolytic AgentsTranexamic Acid

Autor:innen und Institutionen

  • Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, MD, USA.
  • Department of Obstetrics and Gynecology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
  • Department of Anesthesiology, Perioperative and Pain Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • GRITA - Groupe de Rec, herche sur les formes Injectables et les Technologies Associées, Université de Lille, Lille, France.
  • CHU Lille, Institut de Pharmacie, Lille, France.
  • CHU Lille, Pôle anesthésie-réanimation, maternité Jeanne de Flandre, Lille, France.

ORCID-Profile: Allison Dunn, Jogarao V S Gobburu

Förderung

  • NICHD NIH HHS

Zitieren

APA

Dunn, A., Felfeli, M., Seifert, S. M., Gilliot, S., Ducloy-Bouthors, A. S., Shakur-Still, H., Geer, A., Grassin-Delyle, S., Luban, N. L., van den Anker, J. N., Gobburu, J. V. S., Roberts, I., & Ahmadzia, H. K. (2025). Evaluating Tranexamic Acid Dosing Strategies for Postpartum Hemorrhage: A Population Pharmacokinetic Approach in Pregnant Individuals. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70031

Vancouver

Dunn A, Felfeli M, Seifert SM, Gilliot S, Ducloy-Bouthors AS, Shakur-Still H, et al. Evaluating Tranexamic Acid Dosing Strategies for Postpartum Hemorrhage: A Population Pharmacokinetic Approach in Pregnant Individuals. The Journal of Clinical Pharmacology. 2025. doi:10.1002/jcph.70031

BibTeX
@article{Dunn2025,
  author = {Dunn, Allison and Felfeli, Mina and Seifert, Sebastian M and Gilliot, Sixtine and Ducloy-Bouthors, Anne-Sophie and Shakur-Still, Haleem and Geer, Amber and Grassin-Delyle, Stanislas and Luban, Naomi L and van den Anker, Johannes N and Gobburu, Jogarao V S and Roberts, Ian and Ahmadzia, Homa K},
  title = {Evaluating Tranexamic Acid Dosing Strategies for Postpartum Hemorrhage: A Population Pharmacokinetic Approach in Pregnant Individuals},
  journal = {The Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/jcph.70031}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche